Stephanie Dancer, a medical microbiologist, has joined the scientific advisory board of MGB Biopharma, a Scotland-based developer of anti-infectives. She will help oversee the development of the company’s lead antibiotic candidate, which is due to enter the clinic for Clostridium difficile. Dr Dancer is employed by the National Health Service Scotland where she has been a member of several national working groups on antibiotic prescribing and hospital-acquired infections.
MGB Biopharma announced the appointment on 2 June 2014.
Copyright 2014 Evernow Publishing Ltd